Thromb Haemost 2006; 96(04): 542-543
DOI: 10.1160/TH06-06-0307
Letters to the Editor
Schattauer GmbH

Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs

Annarita Tagliaferri
1   Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy
,
Gianna Franca Rivolta
1   Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy
,
Gina Rossetti
3   Transfusion and Hemophilia Center, S. Chiara Hospital, Trento, Italy
,
Corrado Pattacini
1   Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy
,
Giorgio Gandini
2   Transfusion and Hemophilia Center, City Hospital of Verona, Verona, Italy
,
Massimo Franchini
2   Transfusion and Hemophilia Center, City Hospital of Verona, Verona, Italy
› Author Affiliations
Further Information

Publication History

Received 06 June 2006

Accepted after minor revision 07 August 2006

Publication Date:
29 November 2017 (online)

 

 
  • References

  • 1 Valentino LA. Secondary prophylaxis therapy: what are benefits, limitations and unknown?. Haemophilia 2004; 10: 147-57.
  • 2 Miners AH, Sabin CA, Tolley KH. et al. Assessing the effectiveness and cost-effectiveness of prophylaxis against bleeding in patients with severe haemophilia and severe von Willebrand’s disease. J Intern Med 1998; 244: 515-22.
  • 3 Loverin JA, Mensah P, Nokes TJC. Limited prophylaxis in adults with severe hemophilia: a pilot study. Haemophilia 2000; 06: 274-5 [abstract].
  • 4 Saba HI, Tannenbaum B, Morelli G. et al. Factor prophylaxis in the management of adult hemophiliacs. Haemophilia 2000; 06: 276-7 [abstract].
  • 5 Schramm W, Royal S, Kroner B. et al. Clinical outcomes and resource utilization associated with haemophilia care in Europe. Haemophilia 2002; 08: 33-43.
  • 6 Fischer K, Van Dijk K, Van den Berg HM. Late prophylaxis for severe hemophilia: effects of prophylaxis started in adulthood. J Thromb Haemost 2005; 03 (Suppl. 01) OR205. [abstract].
  • 7 Coppola A, Cimino E, Macarone NPalmieri. et al. Clinical and pharmacoeconomic impact of secondary prophylaxis in young-adults with severe hemophilia A. J Thromb Haemost 2005; 03 (Suppl. 01) P1428. [abstract].
  • 8 Gilbert MS. Prophylaxis: Musculoskeletal evaluation. Semin Hematol 1993; 30 (03) Suppl (Suppl. 02) 3-6.
  • 9 Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of hemophilic arthropathy. Clin Orthop Relat Res 1980; 149: 153-9.